Organization | Sunshine Lake Pharma Co., Ltd.

Sunshine Lake Pharma Co., Ltd. Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4

Founded: Donguang China (1992)

Status: Left NME R&D (2003)

Organization Overview

First Clinical Trial

2011

NCT01805648

First Marketed Drug

2011

zidovudine (retrovir)

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

Hec Pharm | HEC PHARM | HEC PHARM CO LTD | Shenyang Sunshine Pharmaceutical Co., LTD. | SUNSHINE | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | SUNSHINE LAKE | Sunshine Lake Pharma Co., Ltd.

Active Ingredients

Marketed Drugs (29)

amlodipine (norvasc) (2018)

apixaban (eliquis) (2019)

azithromycin (zithromax) (2018)

brivaracetam (briviact) (2022)

clarithromycin (biaxin) (2015)

duloxetine (Cymbalta) (2021)

entacapone (comtan) (2018)

entecavir (baraclude) (2020)

esomeprazole (nexium) (2018)

febuxostat (uloric) (2020)

fingolimod (gilenya) (2019)

ibuprofen (motrin) (2018)

levofloxacin (levaquin) (2019)

linagliptin (tradjenta) (2021)

metformin (glucophage) (2018)

moxifloxacin (avelox) (2018)

olanzapine (zyprexa) (2018)

olmesartan (benicar) (2019)

oseltamivir (tamiflu) (2020)

prasugrel (effient) (2019)

ranolazine (ranexa) (2020)

rosuvastatin (crestor) (2020)

sildenafil (viagra) (2020)

sodium chloride (2019)

solifenacin (vesicare) (2020)

tadalafil (cialis) (2019)

tenofovir alafenamide (genvoya) (2021)

ticagrelor (brilinta) (2020)

zidovudine (retrovir) (2011)

Drugs in Phase 4 Trials (3)

epiao (2 trials)

epoetin (Epogen) (5 trials)

thrombopoietin (4 trials)

Drugs in Phase 3 Trials (17)

azacitidine (vidaza) (1 trial)

clifutinib (4 trials)

cytarabine (cytosar-u) (1 trial)

decitabine (dacogen) (1 trial)

etanercept (enbrel) (2 trials)

Filgrastim (neupogen) (1 trial)

fludarabine (fludara) (1 trial)

hec113995pa (4 trials)

idarubicin (idamycin) (1 trial)

irinotecan (Camptosar) (1 trial)

lerotinib (3 trials)

ranibizumab (lucentis) (4 trials)

sofosbuvir (sovaldi) (3 trials)

tegafur (1 trial)

winfuran (1 trial)

yimitasvir (5 trials)

Drugs in Phase 2 Trials (19)

609a (3 trials)

betamethasone (celestone) (1 trial)

cetuximab (erbitux) (2 trials)

cpgj602 (2 trials)

doxorubicin (Doxil) (1 trial)

entecavir (baraclude) (4 trials)

gefitinib (iressa) (1 trial)

gls4 (4 trials)

hec121120 (1 trial)

hec169096 (1 trial)

hec585 (6 trials)

kn046 (1 trial)

ningetinib (6 trials)

pirfenidone (esbriet) (2 trials)

ritonavir (Norvir) (4 trials)

ssgj-613 (2 trials)

yiqibuvir (4 trials)

z650 (3 trials)

Drugs in Phase 1 Trials (38)

candida urate oxidase (1 trial)

dulaglutide (trulicity) (1 trial)

freethiadine (1 trial)

gemcitabine (gemzar) (1 trial)

hec116094 (1 trial)

hec122505msoh (1 trial)

hec30654acoh (1 trial)

hec53856 (3 trials)

hec68498 (1 trial)

hec 68498 (1 trial)

hec73077 (1 trial)

hec83518 (2 trials)

hec89736 (1 trial)

hec93077 (1 trial)

hec96719 (3 trials)

humanized tnf-alpha monoclonal antibody (1 trial)

insulin degludec (tresiba) (1 trial)

itraconazole (sporanox) (1 trial)

kangdaprevir (1 trial)

liraglutide (victoza) (1 trial)

litapiprant (1 trial)

midazolam (versed) (1 trial)

narfurine (1 trial)

nintedanib (ofev) (1 trial)

pegloticase (krystexxa) (1 trial)

probenecid (colbenemid) (1 trial)

pyroglutamic acid (3 trials)

ribavirin (virazole) (5 trials)

rifampin (2 trials)

rituximab (rituxan) (1 trial)

rongliflozin (3 trials)

roxadustat (1 trial)

ssgj-705 (1 trial)

sss17 (2 trials)

tenofovir (viread) (1 trial)

tenofovir alafenamide (genvoya) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Anemia (Phase 4)

Arthritis (Phase 3)

Arthritis, Rheumatoid (Phase 3)

Carcinoma (Phase 2)

Carcinoma, Hepatocellular (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Renal Cell (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Colorectal Neoplasms (Phase 2)

Communicable Diseases (Phase 2)

Depressive Disorder (Phase 1)

Depressive Disorder, Major (Phase 1)

Edema (Phase 1)

Esophageal Neoplasms (Phase 3)

Esophageal Squamous Cell Carcinoma (Phase 2)

Fatty Liver (Phase 1)

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis B (Phase 2)

Hepatitis B, Chronic (Phase 2)

Hepatitis C (Phase 3)

Hepatitis C, Chronic (Phase 2)

Hepatitis, Chronic (Phase 2)

Idiopathic Pulmonary Fibrosis (Phase 1)

Infections (Phase 3)

Kidney Diseases (Phase 1)

Kidney Failure, Chronic (Phase 2)

Leukemia (Phase 1)

Leukemia, Myeloid (Phase 1)

Leukemia, Myeloid, Acute (Phase 1)

Liver Cirrhosis (Phase 1)

Liver Diseases (Phase 1)

Macular Degeneration (Phase 1)

Macular Edema (Phase 1)

Neoplasms (Phase 1)

Non-alcoholic Fatty Liver Disease (Phase 1)

Pancreatic Neoplasms (Phase 1)

Pruritus (Phase 1)

Psoriasis (Phase 1)

Pulmonary Eosinophilia (Phase 1)

Pulmonary Fibrosis (Phase 1)

Purpura (Phase 3)

Purpura, Thrombocytopenic (Phase 3)

Purpura, Thrombocytopenic, Idiopathic (Phase 4)

Renal Insufficiency (Phase 2)

Renal Insufficiency, Chronic (Phase 2)

Retinal Vein Occlusion (Phase 2)

Sleep Initiation and Maintenance Disorders (Phase 1)

Spondylitis (Phase 3)

Spondylitis, Ankylosing (Phase 3)

Thrombocytopenia (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 107
# of Trial APIs: 77